Q1 2023 Holdings
Filed 2023-05-15 | 77 holdings | $965.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $158.5M | 2,080,000 | 16.4% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $58.8M | 5,312,222 | 6.1% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $51.8M | 2,127,043 | 5.4% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $38.5M | 1,248,147 | 4.0% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $31.5M | 156,096 | 3.3% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $31.0M | 456,500 | 3.2% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $30.5M | 136,235 | 3.2% |
| Iradimed Corp(IRMD) | COM | 46266A109 | $30.4M | 773,694 | 3.2% |
| Smith & Nephew PLC(SNN) | SPDN ADR NEW | 83175M205 | $27.1M | 970,200 | 2.8% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $21.0M | 9,853,063 | 2.2% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $20.9M | 1,060,983 | 2.2% |
| Surmodics Inc(SU6) | COM | 868873100 | $20.3M | 892,678 | 2.1% |
| CVS Health Corp(CVS) | COM | 126650100 | $18.1M | 243,554 | 1.9% |
| Celcuity Inc(CELC) | COM | 15102K100 | $17.3M | 1,687,933 | 1.8% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $16.9M | 12,803,015 | 1.8% |
| Axogen Inc(AXGN) | COM | 05463X106 | $16.8M | 1,779,998 | 1.7% |
| Natera Inc(NTRA) | COM | 632307104 | $16.3M | 294,200 | 1.7% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $15.9M | 174,592 | 1.6% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $14.4M | 71,000 | 1.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $14.3M | 380,250 | 1.5% |
| The Beauty Health Company(SKIN) | COM CL A | 88331L108 | $13.8M | 1,089,952 | 1.4% |
| Jasper Therapeutics Inc | COM | 471871103 | $13.5M | 7,454,980 | 1.4% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $12.3M | 4,145,117 | 1.3% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $11.6M | 4,321,197 | 1.2% |
| Humana Inc(HUM) | COM | 444859102 | $11.5M | 23,750 | 1.2% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $11.3M | 750,300 | 1.2% |
| Neuropace Inc(NPCE) | COM | 641288105 | $11.3M | 2,428,714 | 1.2% |
| Vericel Corp(VCEL) | COM | 92346J108 | $9.6M | 326,449 | 1.0% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $9.4M | 113,700 | 1.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $8.9M | 1,449,777 | 0.9% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $8.8M | 411,800 | 0.9% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $8.3M | 438,002 | 0.9% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $8.3M | 203,300 | 0.9% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $8.1M | 469,400 | 0.8% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $7.8M | 130,000 | 0.8% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $7.7M | 460,000 | 0.8% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $7.5M | 494,000 | 0.8% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $7.5M | 2,387,020 | 0.8% |
| Theratechnologies Inc | COM | 88338H100 | $7.4M | 9,090,511 | 0.8% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $6.8M | 85,179 | 0.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $6.8M | 322,600 | 0.7% |
| Genedx Holdings Corp(SMFRUSD) | COM CL A | 81663L101 | $6.5M | 17,940,000 | 0.7% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $6.5M | 230,000 | 0.7% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $6.3M | 101,450 | 0.6% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $6.2M | 236,900 | 0.6% |
| Karuna Therapeutics Inc | COM | 48576A100 | $6.1M | 33,740 | 0.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $6.0M | 364,000 | 0.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $5.8M | 242,000 | 0.6% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $5.3M | 234,600 | 0.5% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $5.2M | 122,316 | 0.5% |